Personalized medicine: paradigm shift in ALK positive non-small cell lung cancer: a case report
Abstract Background Since the identification of multiple therapeutic targets, as is the case of anaplastic lymphoma kinase (ALK) translocation, the paradigm of treating patients with non-small cell lung cancer (NSCLC) has improved. In order to guarantee the possibility of longer survival outcomes wi...
Wedi'i Gadw mewn:
| Prif Awduron: | , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMC
2023-09-01
|
| Cyfres: | Journal of Medical Case Reports |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1186/s13256-023-04107-5 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|